Cargando…

Identification of a cholesterol metabolism-related prognostic signature for multiple myeloma

Multiple myeloma (MM) is a prevalent hematological malignancy that poses significant challenges for treatment. Dysregulated cholesterol metabolism has been linked to tumorigenesis, disease progression, and therapy resistance. However, the correlation between cholesterol metabolism-related genes (CMG...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhao, Na, Qu, Chunxia, Yang, Yan, Li, Huihui, Li, Yueyue, Zhu, Hongbo, Long, Zhiguo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10632470/ https://www.ncbi.nlm.nih.gov/pubmed/37938654 http://dx.doi.org/10.1038/s41598-023-46426-z

Ejemplares similares

Identification of a novel cuproptosis‐related gene signature for multiple myeloma diagnosis
por: Zhu, Yidong, et al.
Publicado: (2023)

Identification and Validation of a Potential Prognostic 7-lncRNA Signature for Predicting Survival in Patients with Multiple Myeloma
por: Zhong, Yun, et al.
Publicado: (2020)

Establishment and validation of a cholesterol metabolism-related prognostic signature for hepatocellular carcinoma
por: Tang, Linsong, et al.
Publicado: (2022)

Identification of a Pyroptosis-Related Prognostic Signature Combined With Experiments in Hepatocellular Carcinoma
por: Li, Huihui, et al.
Publicado: (2022)

Development and Validation of a 9-Gene Prognostic Signature in Patients With Multiple Myeloma
por: Liu, Xiao-Ping, et al.
Publicado: (2019)

Identification and validation of a novel cuproptosis-related gene signature in multiple myeloma
por: Zhang, Bingxin, et al.
Publicado: (2023)

A Network Analysis of Multiple Myeloma Related Gene Signatures
por: Liu, Yu, et al.
Publicado: (2019)

Integrative analysis of the prognostic value and immune microenvironment of mitophagy-related signature for multiple myeloma
por: Jia, Yachun, et al.
Publicado: (2023)

Identification and validation of potential prognostic lncRNA biomarkers for predicting survival in patients with multiple myeloma
por: Zhou, Meng, et al.
Publicado: (2015)

Identification and Validation of a Novel RNA-Binding Protein-Related Gene-Based Prognostic Model for Multiple Myeloma
por: Wang, Wei, et al.
Publicado: (2021)

An interactive nomogram based on clinical and molecular signatures to predict prognosis in multiple myeloma patients
por: Liu, Linxin, et al.
Publicado: (2021)

Identification of Metabolism-Related Genes Influencing Prognosis of Multiple Myeloma Patients
por: Wang, Rui, et al.
Publicado: (2021)

Arachidonic acid is associated with dyslipidemia and cholesterol-related lipoprotein metabolism signatures
por: Li, Fan, et al.
Publicado: (2022)

Identification of an Autophagy-Related Signature Based on Whole Bone Marrow Sequencing for the Prognosis and Immune Microenvironment Characterization of Multiple Myeloma
por: Li, Licheng, et al.
Publicado: (2022)

Systematic discrimination of the repetitive genome in proximity of ferroptosis genes and a novel prognostic signature correlating with the oncogenic lncRNA CRNDE in multiple myeloma
por: Qin, Jiading, et al.
Publicado: (2022)

Prognostic Potential of Heart Rate and Hypertension in Multiple Myeloma Patients
por: Wang, Jie, et al.
Publicado: (2021)

Prognostic significance of FSCN family in multiple myeloma
por: Deng, Cong, et al.
Publicado: (2021)

Identification of clinical implications and potential prognostic models of chromatin regulator mutations in multiple myeloma
por: Zhang, Lina, et al.
Publicado: (2022)

Prognostic factors and classification in multiple myeloma.
por: San Miguel, J. F., et al.
Publicado: (1989)

A prognostic index for multiple myeloma.
por: Grignani, G., et al.
Publicado: (1996)

The Evolution of Prognostic Factors in Multiple Myeloma
por: Hanbali, Amr, et al.
Publicado: (2017)

Immunological Prognostic Factors in Multiple Myeloma
por: Bębnowska, Dominika, et al.
Publicado: (2021)

Identification of pyroptosis‐related gene prognostic signature in head and neck squamous cell carcinoma
por: Li, Zhanzhan, et al.
Publicado: (2022)

Components of metabolic syndrome in patients with multiple myeloma and smoldering multiple myeloma
por: Markus, Efrat, et al.
Publicado: (2020)

Identification of cuproptosis and immune-related gene prognostic signature in lung adenocarcinoma
por: Zhang, Wentao, et al.
Publicado: (2023)

Identification of a prognostic signature of nine metabolism-related genes for hepatocellular carcinoma
por: Tang, Chaozhi, et al.
Publicado: (2020)

Developing mRNA signatures as a novel prognostic biomarker predicting high risk multiple myeloma
por: Wang, Jing, et al.
Publicado: (2023)

Metabolic Features of Multiple Myeloma
por: El Arfani, Chaima, et al.
Publicado: (2018)

Metabolic Disorders in Multiple Myeloma
por: Gavriatopoulou, Maria, et al.
Publicado: (2021)

Metabolic Vulnerabilities in Multiple Myeloma
por: Lim, Julia S. L., et al.
Publicado: (2022)

Incidence of Arrhythmias and Their Prognostic Value in Patients With Multiple Myeloma
por: Li, Yongxin, et al.
Publicado: (2021)

Identification of High Serum Apolipoprotein A1 as a Favorable Prognostic Indicator in Patients with Multiple Myeloma
por: Liang, Lifan, et al.
Publicado: (2019)

Deep Phenotyping Reveals Distinct Immune Signatures Correlating with Prognostication, Treatment Responses, and MRD Status in Multiple Myeloma
por: Papadimitriou, Konstantinos, et al.
Publicado: (2020)

FABP5, a Novel Immune-Related mRNA Prognostic Marker and a Target of Immunotherapy for Multiple Myeloma
por: Jia, Haipeng, et al.
Publicado: (2021)

Identification of the immune checkpoint signature of multiple myeloma using mass cytometry‐based single‐cell analysis
por: Wang, Jinheng, et al.
Publicado: (2020)

Identification of CD8(+) T-cell epitope from multiple myeloma-specific antigen AKAP4
por: Ma, Ning, et al.
Publicado: (2022)

Prognostic and predictive biomarker developments in multiple myeloma
por: Wallington-Beddoe, Craig T., et al.
Publicado: (2021)

Diagnostic and Prognostic Value of PACAP in Multiple Myeloma
por: Tóth, Tünde, et al.
Publicado: (2023)

Bendamustine, pomalidomide, and dexamethasone for relapsed and/or refractory multiple myeloma
por: Sivaraj, Dharshan, et al.
Publicado: (2018)

A novel ferroptosis-related gene signature for predicting prognosis in multiple myeloma
por: Gao, Dandan, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_7hgn4omc2dvc76ifl8t4flkr78